Goodwin, J., Neugent, M. L., Lee, S. Y., Choe, J. H., Choi, H., Jenkins, D. M. R., . . . Kim, J. (2017). The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat Commun.
Chicago-tyylinen lähdeviittausGoodwin, Justin, et al. "The Distinct Metabolic Phenotype of Lung Squamous Cell Carcinoma Defines Selective Vulnerability to Glycolytic Inhibition." Nat Commun 2017.
MLA-viiteGoodwin, Justin, et al. "The Distinct Metabolic Phenotype of Lung Squamous Cell Carcinoma Defines Selective Vulnerability to Glycolytic Inhibition." Nat Commun 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.